Orbimed Advisors, 10% Owner: Traws Pharma TRAW Buy · Filed 04/28

Trade details

Type: Insider buy
Amount: $998,207.43
Shares · price: 597,729 sh · $1.67 a share
Held after: 1,203,250 sh
Stock: Traws Pharma TRAW
Person: Orbimed Advisors10% Owner
Trade date: 26/04/16
Filed: 26/04/28
Days to filing: 12 days

First buy since 2023

Insiders buying this week: 2 insiders
Holding change: +98.7%

Traws Pharma trades, last 26 weeks

What else happened in Traws Pharma around then

Filed or reported within 30 days of the trade day · 03/17~05/16

Orbimed Advisors's recent trades

Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$10M
588,235 sh
$10M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$15M
1,000,000 sh
$15M
Filed 09/23
Traded 09/21
Orbimed AdvisorsDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$5M
333,333 sh
$5M
Filed 09/23
Traded 09/21